NCT00116870View on ClinicalTrials.gov

MARS - Monitored Atherosclerosis Regression Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

June 30, 1985

Primary Completion Date

February 29, 1992

Study Completion Date

February 29, 1992

Conditions
AtherosclerosisCoronary Artery Disease
Interventions
DRUG

lovastatin

Trial Locations (1)

90033

Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine, Los Angeles

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00116870 - MARS - Monitored Atherosclerosis Regression Study | Biotech Hunter | Biotech Hunter